CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Developmental biology - Apoptosis|
Apoptosis Errors Clue to Some Birth Defects
The new research also suggests abnormalities in cell death processes likely contribute to some common birth defects in humans, such as spina bifida, heart vessel defects and cleft palate.
Cell death link to birth defects
Programmed cell death, also known as apoptosis, is a normal process that rids the body of sick, damaged or unwanted cells in a controlled way, limiting side effects and damage to the body. It was first described as having a role in embryonic development in the 1940s. Over the past 70 years, numerous studies also implicated it as crucial role in most stages and tissues during development.
However, in this new study, it became clear that apoptosis is not as critical to development as previously thought. According to Francine Ke PhD, from the Department of Medical Biology at The University of Melbourne,in Victoria, Australia: "Rather, apoptosis was essential at specific places and times during development, but unnecessary in others. We identified the tissues and organs that critically require apoptosis to develop normally, and made the surprise discovery that many do not require it at all.
"Our research showed that when cell death is not functioning properly, it commonly leads to defects in neural tube development, for example spina bifida, heart vessel defects and facial abnormalities, such as cleft palate."
Associate Professor Anne K. Voss PhD, believed the biggest surprise came from the discovery of tissues that do not require apoptosis at all for normal development saying: "For some time, it has been a widely-held belief that programmed cell death is necessary for the shaping of certain tissues and structures during development. But, to our surprise, many tissues in which programmed cell death was - for very good reasons - considered absolutely essential - is not required at all.
"For example, apoptosis was thought to play a particularly important role in 'hollowing out' body cavities and ducts in internal organs during development. However we show in the absence of apoptosis, most tissues and organs develop normally. It may surprise researchers just how precise and limited the effects of apoptosis are in embryonic development."
Pro-death function confirmed
To determine the role of apoptosis in development, the team eliminated pro-death proteins BAK and BAX, and a similar protein BOK, whose function was unclear - until now.
"In this paper we have solved the structure of BOK using the Australian Synchrotron, and once and for all confirmed that BOK is a pro-death proteins BAK and BAX, and a similar protein BOK, whose function was unclear until now."
• Control of embryonic cell survival by BCL-2 family proteins is finely balanced
• Combined loss of single alleles of Mcl-1 and Bcl-x causes craniofacial defects
• Loss of one allele of Bimrestores normal development to Mcl-1+/-;Bcl-x+/- pups
Apoptotic cell death removes unwanted cells and is regulated by interactions between pro-survival and pro-apoptotic members of the BCL-2 protein family. The regulation of apoptosis is thought to be crucial for normal embryonic development. Accordingly, complete loss of pro-survival MCL-1 or BCL-XL (BCL2L1) causes embryonic lethality. However, it is not known whether minor reductions in pro-survival proteins could cause developmental abnormalities. We explored the rate-limiting roles of MCL-1 and BCL-XL in development and show that combined loss of single alleles of Mcl-1 and Bcl-x causes neonatal lethality. Mcl-1+/–;Bcl-x+/– mice display craniofacial anomalies, but additional loss of a single allele of pro-apoptotic Bim(Bcl2l11) restores normal development. These findings demonstrate that the control of cell survival during embryogenesis is finely balanced and suggest that some human craniofacial defects, for which causes are currently unknown, may be due to subtle imbalances between pro-survival and pro-apoptotic BCL-2 family members.
Stephanie Grabow, Andrew J. Kueh, Francine Ke, Hannah K. Vanyai, Bilal N. Sheikh, Michael A. Dengler, William Chiang, Samantha Eccles, Ian M. Smyth, Lynelle K. Jones, Frederic J. de Sauvage, Mark Scott, Lachlan Whitehead and Anne K. Voss.
The research was supported by the Australian National Health and Medical Research Council, Cancer Council Victoria, Lady Tata Memorial Trust, Leukaemia Foundation of Australia, Leukemia & Lymphoma Society (US) and the Victorian Government.
Return to top of page
Subtle changes in levels of BCL-2 proteins cause severe craniofacial abnormalities and are often associated with fetal or infant death, as well as with intellectual and/or physical disability.
Image credit: Stephanie Grabow PhD.